All possible acute diseases of the upper airways are commonly counted under the term “flu”.
However, the extent of a “classical” influenza epidemic is not known to the majority of the population.
The WHO and the vast majority of experts assume that an increased incidence of influenza will have to be expected in the foreseeable future.

The virus is transmitted by droplets. However, transmission can also take place through contact with viruses that adhere to objects. The course of the disease is different in different age groups. Particularly feared is the rarer influenza pneumonia (pneumonia caused by the influenza virus) and the more frequently occurring bacterial pneumonia, occurring in the later course of the disease. Inflammations of the pericardium and myocardium are rare complications. Severe disease progressions are observed above all in older persons or persons already weakened by other diseases. Due to the changing properties of influenza viruses, annual vaccination with a vaccine with a current composition recommended by the WHO is necessary.

Vaccination: Composed of components of cultured and inactivated influenza viruses.

Who should vaccinate?

  • persons over 60 years of age
  • persons at risk to their health as a result of a basic condition (eg chronic lung, cardiovascular, liver and kidney diseases, diabetes and other metabolic diseases, immunodeficiency, HIV infection),
  • persons caring for the aforementioned (medical and nursing staff, family members, etc.)
  • persons in establishments with extensive public traffic.

Time of vaccination: Annual vaccination especially in early autumn.

Common vaccination reactions: Well tolerated if contraindications are observed, occasionally redness and swelling at the site of injection, less frequent general reactions such as discomfort, fatigue, headache, muscle and limb pain.